Pa. Panel Won't DQ Goodwin Procter In Teva Coverage Row
By Jeannie O'Sullivan ( November 2, 2018, 8:48 PM EDT) -- A split Pennsylvania state appeals court on Friday backed a lower court's decision allowing Goodwin Procter LLP to continue representing Teva Pharmaceuticals USA Inc. in a suit against Impax Laboratories Inc. seeking indemnity for losses in a false advertising suit over the antidepressant Budeprion, ruling that the firm's prior Budeprion-related work on Impax's behalf didn't constitute a conflict....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.